Efficient TCR gene editing in T lymphocytes
US12239664B2 · kind B2 · utility
0Cited by
2References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 24, 2022 |
| Grant date | Mar 4, 2025 |
| Priority date | — |
| Expiry date | Apr 1, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2800/80
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to engineered T cells and methods of making and using the same, as well as reagents for making the engineered T cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.